A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Bristol-Myers Squibb
Study ID
NCT06979453
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Deucravacitinib — DRUG
    Specified dose on specified days
  • Placebo — OTHER
    Specified dose on specified days

Study Details

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis

Key Dates

Start date
Dec 3, 2025
Status verified
May 2026
Primary completion
Oct 12, 2029
Completion
Aug 12, 2034

Study Design

Enrollment
366 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Administration of Deucravacitinib
  • Placebo Comparator: Placebo

Primary Outcome Measure

Number of participants achieving at least 75% improvement in Psoriasis Area and Severity Index (PASI 75) [ Time Frame: At week 16 ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (42)

FacilityCityStateZIPSite coordinators
Local Institution - 0041BirminghamAlabama35243
Site 0041
Local Institution - 0261BirminghamAlabama35203
Site 0261
Local Institution - 0053PhoenixArizona85006-
Local Institution - 0025Fountain ValleyCalifornia92708
Site 0025
Center For Dermatology Clinical Research, Inc.FremontCalifornia94538
Sunil Dhawan, Site 0090
510-599-4750
Dermatology Research AssociatesLos AngelesCalifornia90045
Howard Sofen, Site 0006
310-337-7171
Northridge Clinical TrialsNorthridgeCalifornia91325
Navid Ezra, Site 0214
818-350-7483
Local Institution - 0077SacramentoCalifornia95814
Site 0077
Golden State Dermatology - Walnut Creek - Ygnacio Valley RoadWalnut CreekCalifornia94598
Michael Wang, Site 0243
507-261-3758
Paradigm Clinical Research, LLCWheat RidgeColorado80033
Kimberly Neyman, Site 0231
303-463-1947
Local Institution - 0021ClearwaterFlorida33756
Site 0021
Life Clinical TrialsMargateFlorida33063
Eli Saleeby, Site 0185
954-849-0902
Skin Research of South FloridaMiamiFlorida33173
Giovanna Ciocca, Site 0043
305-707-9852
Wellness Clinical ResearchMiami LakesFlorida33016
David Rodriguez, Site 0014
786-483-7856
MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical ResearchTampaFlorida33607
Stephen Lockwood, Site 0070
813-948-7550
USF HealthTampaFlorida33612
Sharon Albers, Site 0171
813-974-4381
Dermatology Affiliates Research InstituteAtlantaGeorgia30305
Adebayo Akinsola, Site 0244
770-733-1077
Advanced Medical Research, PC.Sandy SpringsGeorgia30328
Jamie Weisman, Site 0072
404-939-9220
Dawes Fretzin Clinical Research Group, LLCIndianapolisIndiana46250
Scott Fretzin, Site 0003
317-516-5030
Local Institution - 0262MurrayKentucky42071
Site 0262
Local Institution - 0202MetairieLouisiana70001
Site 0202
Dermatology and Skin Cancer Specialists, LLCRockvilleMaryland20850
Benjamin Lockshin, Site 0061
301-355-3183
Kuchnir Dermatology & Dermatologic SurgeryMilfordMassachusetts01757
Shiu-Chung Au, Site 0220
000-000-0000
Local Institution - 0095DetroitMichigan48201
Site 0095
Local Institution - 0233ColumbiaMissouri65201
Site 0233
Local Institution - 0266Lee's SummitMissouri64064
Site 0266
JDR Dermatology ResearchLas VegasNevada89148
James Del Rosso, Site 0052
702-596-6137
Local Institution - 0281RobbinsvilleNew Jersey08691
Site 0281
Local Institution - 0166The BronxNew York10467
Site 0166
Local Institution - 0234HickoryNorth Carolina28602-
Apex Clinical Research Center - CantonCantonOhio44716
Jorge Garcia-Zuazaga, Site 0251
14404404430440
Local Institution - 0271ColumbusOhio43228
Site 0271
Local Institution - 0275LorainOhio44053
Site 0275
Apex Clinical Research CenterMayfield HeightsOhio44124
Jorge Garcia-Zuazaga, Site 0055
14404404430440
Paddington Testing CompanyPhiladelphiaPennsylvania19103
Jennifer Parish, Site 0073
215-563-7330
ObjectiveHealth - Goodlettsville Dermatology ResearchGoodlettsvilleTennessee37072
Keith Loven, Site 0235
615-241-2820
Local Institution - 0248NashvilleTennessee37205-
Texas Dermatology and Laser SpecialistsSan AntonioTexas78218
John Browning, Site 0033
210-704-4037
Local Institution - 0280SouthlakeTexas76092
Site 0280
Local Institution - 0045NorfolkVirginia23502
Site 0045
Frontier Derm PartnersMill CreekWashington98012
Eingun Song, Site 0071
425-275-4404
Local Institution - 0264SpokaneWashington99204
Site 0264

Find similar trials in Birmingham, AL

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Local Institution - 0041· Birmingham, ALLocal Institution - 0261· Birmingham, ALLocal Institution - 0053· Phoenix, AZLocal Institution - 0025· Fountain Valley, CACenter For Dermatology Clinical Research, Inc.· Fremont, CADermatology Research Associates· Los Angeles, CA

Related Studies